Shareholding for the Period Ended June 30, 2017
Lyka Labs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here12-07-2017
12-07-2017
Notice Of EGM On 3Rd August, 2017
Notice of EGM convened on Thursday, 3rd August, 2017 at 12.15 p.m. at our registered office at Ankleshwar for seeking the approval of shareholders to the proposed issue of warrants and shares on preferential basis to promoter and non-promoters.10-07-2017
Updates
The Company has been publishing Consolidated Financial Results in the past few years. The Company has changed its policy and for the First Quarter of the current Financial year ended on 30th June, 2017 and onwards it shall publish Unaudited Standalone Financial Results instead of Unaudited Consolidated Financial Results. The Company shall follow this practice uniformly throughout the Financial Year.04-07-2017
Outcome of Board Meeting
At the Board meeting held today, the Board has decided to offer and issue 5,50,000 (Five Lakhs & fifty thousand) convertible warrants to Shri. N. I. Gandhi, promoter of the Company and 61,00,000 (Sixtyone Lakhs) equity shares to non promoters on preferential basis as under: Name Number of equity shares Shri. Mayank J Shah 20,00,000 Smt. Shruti M. Shah 15,00,000...04-07-2017
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nehal N Gandhi30-06-2017
Board Meeting On 4Th July, 2017
Board Meeting is convened on 4th July, 2017 to consider Issue of Equity shares/warrants on preferential Basis to promoters/Non-Promoters at a price to be determined as per SEBI(ICDR) Regulations and also consider convening of General Meeting of members of the Company.29-06-2017
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Narendra I Gandhi HUF16-06-2017
Updates
Filing of Documents of merger of Lyka Healthcare Limited wholly owned subsidiary with Lyka Labs Limited w.e.f 1st April, 2017 in terms of SEBI circular dated 10th March, 201730-05-2017
Lyka Labs inks out-licensing deal with US-based generics firm
The market size of the licensed formulations is about $ 1.4 bn as per IMS March 2017, says Lyka30-05-2017